A living WHO guideline on drugs to prevent covid-19

2021149 citationsJournal Articlebronze Open Access

Authors

François Lamontagne · Kleijnen Systematic Reviews (United Kingdom)

Miriam Stegemann · Charité - Universitätsmedizin Berlin

Arnav Agarwal · Kleijnen Systematic Reviews (United Kingdom)

Thomas Agoritsas · Kleijnen Systematic Reviews (United Kingdom)

Reed Siemieniuk · Impact

Bram Rochwerg · Kleijnen Systematic Reviews (United Kingdom)

Jessica Bartoszko

Abstract

This is the first version of the living guideline for drugs to prevent covid-19. It complements the WHO living guideline on drugs to treat covid-19. When citing this article, please consider adding the update number and date of access for clarity.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Chronic Disease Management Strategies Health Policy Implementation Science

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: BMJ

Volume 372, pp. n526-n526

DOI: 10.1136/bmj.n526

Field-Weighted Citation Impact: 40.19